Regulating Together for Prader-Willi Syndrome: A Group Behavioral Therapy for Emotion Dysregulation (NCT07607730)
Adapting a Group Intervention for Emotion Dysregulation in Prader-Willi Syndrome
🩺 Plain-English Summary (8th-Grade Level)
The goal of this study is to help teens with Prader-Willi Syndrome (PWS) and their families learn practical strategies for managing issues like irritability, meltdowns, and anxiety. The main objective of the study is: To adapt current Regulating Together materials to create an outpatient group program for emotion dysregulation in Prader-Willi Syndrome (PWS) that will improve psychosocial outcomes for youth with PWS.
Who can join: Review the eligibility criteria below.
Location: Children's Mercy — Kansas City, Missouri
Age range: 13 Years to 17 Years
🧪 Interventions in This Study
- Regulating Together group therapy (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Children's Mercy — Kansas City, Missouri
📞 Contact the Study Coordinator
Phone: (816) 816-6967
Email: gmanley@cmh.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Prader-Willi Syndrome
- A Study of Setmelanotide in Patients With Prader-Willi Syndrome — Gainesville, Florida
- A Clinical Evaluation of Non-Invasive Vagus Nerve Stimulation for Temper Outbursts in People With PWS — Palo Alto, California
- Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome — Orange, California
- A Study of Pitolisant in Patients With Prader-Willi Syndrome — Los Angeles, California
- Tirzepatide in PWS, HO and GNSO — Saint Paul, Minnesota
Explore by condition: All Prader-Willi Syndrome clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.